FDA postpones first stop on Crawford listening tour

Share this article:
The FDA has postponed the first session in its Vision 2006 consumer listening tour to give FDA Commissioner Lester Crawford and other top FDA officials more time to concentrate on relief efforts in connection with Hurricane Katrina, an FDA spokeswoman told MM&M today. 
The first stop on the question and answer tour to hear consumer concerns was scheduled to take place in Miami on Tuesday, Sept. 13. Rescheduling details were not made available, as Hurricane relief efforts are a "priority" right now, the spokeswoman added.
The Vision 2006 sessions on Nov. 2 in Boston and a Nov. 30 in Phoenix were scheduled to proceed as planned, the agency said.
The 10 a.m. to 4 p.m. sessions will include at least 150 consumers, with time devoted to such issues as drug advertising, conflicts of interest among federal advisers and drug safety.
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in News

Email Newsletters

More in News

Five things for pharma marketers to know: Tuesday, September 2

Five things for pharma marketers to know: Tuesday, ...

Sanofi and Regeneron unveil Phase-III results of their PCSK9; Merck will present data on its anti-PD-1 at the end of this month; WSJ op/ed suggests US should lead fight against ...

Five things for Pharma Marketers to know: Friday, August 29

Five things for Pharma Marketers to know: Friday, ...

Takeda closes out a good-news, bad-news kind of week, AstraZeneca adds a new clinical trial for its experimental PD-1, and researchers link a funeral to the Ebola outbreak.

Amgen sends PCSK9 to FDA

Amgen sends PCSK9 to FDA

Evolocumab holds the FDA's first filed biologics license application for the class.